MSD medicine accepted for use in Scotland
Scotland is the first European country to accept the HIF-2α…
Scotland is the first European country to accept the HIF-2α inhibitor WELIREG® (belzutifan) for eligible adults with von Hippel-Lindau (VHL) disease.